RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      중증 폐동맥고혈압이 동반된 만성폐쇄성폐질환 1예 = Chronic Obstructive Pulmonary Disease with Severe Pulmonary Hypertension : A Case Report

      한글로보기

      https://www.riss.kr/link?id=A75164456

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Pulmonary hypertension is an increase in blood pressure in the pulmonary artery, pulmonary vein or pulmonary capillaries. Depending on the cause, pulmonary hypertension can be a severe disease with markedly decreased exercise tolerance and right-sided...

      Pulmonary hypertension is an increase in blood pressure in the pulmonary artery, pulmonary vein or pulmonary capillaries. Depending on the cause, pulmonary hypertension can be a severe disease with markedly decreased exercise tolerance and right-sided heart failure. Pulmonary hypertension can present as one of five different types: arterial, venous, hypoxic, thromboembolic, or miscellaneous. Chronic obstructive pulmonary disease with severe pulmonary hypertension is a rare disease. A 52-year-old man presented with a complaint of aggravating dyspnea. The mean pulmonary arterial pressure was 61.5 mmHg by Doppler echocardiogram. The patient was prescribed diuretics, digoxin, bronchodilator, sildenafil, bosentan and an oxygen supply. However, he ultimately died of corpulmonale. Thus, diagnosis and early combination therapy are important.

      더보기

      참고문헌 (Reference)

      1 Galiè N, "Sildenafil citrate therapy for pulmonary arterial hypertension" 353 (353): 2148-2157, 2005

      2 Chaouat A, "Severe pulmonary hypertension and chronic obstructive pulmonary disease" 172 (172): 189-194, 2005

      3 "Proceedings of the 3rd world symposium on pulmonary arterial hypertension. Venice, Italy, June 23-25, 2003" 43 (43): 1S-90, 2004

      4 Rich S, "Primary pulmonary hypertension. A national prospective study" 107 (107): 216-223, 1987

      5 Williams BT, "Prevalence of hypoxaemic chronic obstructive lung disease with reference to long-term oxygen therapy" 2 (2): 369-372, 1985

      6 Sitbon O, "Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension" 111 (111): 3105-3111, 2005

      7 Nauser TD, "Diagnosis and treatment of pulmonary hypertension" 63 (63): 1789-1798, 2001

      8 Weitzenblum E, "Chronic cor pulmonale" 89 (89): 225-230, 2003

      9 Rubin LJ, "Bosentan therapy for pulmonary arterial hypertension" 346 (346): 896-903, 2002

      10 Olschewski H, "Aerosolized iloprost randomized study group. Inhaled iloprost for severe pulmonary hypertension" 347 (347): 322-329, 2002

      1 Galiè N, "Sildenafil citrate therapy for pulmonary arterial hypertension" 353 (353): 2148-2157, 2005

      2 Chaouat A, "Severe pulmonary hypertension and chronic obstructive pulmonary disease" 172 (172): 189-194, 2005

      3 "Proceedings of the 3rd world symposium on pulmonary arterial hypertension. Venice, Italy, June 23-25, 2003" 43 (43): 1S-90, 2004

      4 Rich S, "Primary pulmonary hypertension. A national prospective study" 107 (107): 216-223, 1987

      5 Williams BT, "Prevalence of hypoxaemic chronic obstructive lung disease with reference to long-term oxygen therapy" 2 (2): 369-372, 1985

      6 Sitbon O, "Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension" 111 (111): 3105-3111, 2005

      7 Nauser TD, "Diagnosis and treatment of pulmonary hypertension" 63 (63): 1789-1798, 2001

      8 Weitzenblum E, "Chronic cor pulmonale" 89 (89): 225-230, 2003

      9 Rubin LJ, "Bosentan therapy for pulmonary arterial hypertension" 346 (346): 896-903, 2002

      10 Olschewski H, "Aerosolized iloprost randomized study group. Inhaled iloprost for severe pulmonary hypertension" 347 (347): 322-329, 2002

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2022-01-01 학술지명변경 한글명 : Yeungnam University Journal of Medicine -> Journal of Yeungnam Medical Science
      외국어명 : 미등록 -> Journal of Yeungnam Medical Science
      KCI등재
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2016-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.03 0.03 0
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0 0 0 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼